Evidence map›Paper›PMID 41149297›Full record

ArticleBiosensors2025

Simulation of an Asymmetric Photonic Structure Integrating Tamm Plasmon Polariton Modes and a Cavity Mode for Potential Urinary Glucose Sensing via Refractive Index Shifts.

Hung-Che Chou, Rashid G Bikbaev, Ivan V Timofeev, Mon-Juan Lee, Wei Lee

Abstract read
In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hung-Che ChouInstitute of Lighting and Energy Photonics, College of Photonics, National Yang Ming Chiao Tung University, Guiren Dist., Tainan 711010, Taiwan.
Rashid G BikbaevKirensky Institute of Physics, Federal Research Center KSC SB RAS, Krasnoyarsk 660036, Russia.
Ivan V TimofeevKirensky Institute of Physics, Federal Research Center KSC SB RAS, Krasnoyarsk 660036, Russia.ORCID 0000-0002-6558-5607
Mon-Juan LeeDepartment of Chemical and Materials Engineering, National Kaohsiung University of Science and Technology, Sanmin Dist., Kaohsiung 807618, Taiwan.
Wei LeeInstitute of Imaging and Biomedical Photonics, College of Photonics, National Yang Ming Chiao Tung University, Guiren Dist., Tainan 711010, Taiwan.ORCID 0000-0002-3515-1170

Funding

National Science and Technology Council, Taiwan 112-2314-B-309-001, 113-2112-M-A49-022
6 · The paper itself

Abstract

Diabetes has become a global health challenge, driving the demand for innovative, non-invasive diagnostic technologies to improve glucose monitoring. Urinary glucose concentration, a reliable indicator of metabolic changes, provides a practical alternative for frequent monitoring without the discomfort of invasive methods. In this simulation-based study, we propose a novel asymmetric photonic structure that integrates Tamm plasmon polariton (TPP) modes and a cavity mode for high-precision refractive index sensing, with a conceptual focus on the potential detection of urinary glucose. The structure supports three distinct resonance modes, each with unique field localization. Both the TPP modes, confined at the metallic-dielectric interfaces, serve as stable references whose wavelengths are unaffected by refractive-index variations in human urine, whereas the cavity mode exhibits a redshift with increasing refractive index, enabling high responsiveness to analyte changes. The evaluation of sensing performance employs a sensitivity formulation that leverages either TPP mode as a reference and the cavity mode as a probe, thereby achieving dependable measurement and spectral stability. The optimized design achieves a sensitivity of 693 nm·RIU

Indexed as

Biosensing TechniquesGlucoseBlood Chemical AnalysisHumansPhotonsUrinalysisGlucosecavity modediabetes sensingoptical sensorrefractive index sensingTamm plasmon polariton

Identifiers

PMID41149297
PMCPMC12562746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.